Cost-sharing waivers for COVID-19 treatment are due to expire in the upcoming months. Approximately 88% in individual and fully insured group markets have plans that limit out-of-pocket costs for COVID-19 treatment. After factoring waivers that have already expired, roughly 50% of enrollees in such plans will be eligible for waivers through October. The figures do not include those in self-insured plans. Although federal legislation mandates free testing for COVID-19, there is no such legislation capping out-of-pocket costs for COVID-19 treatment. According to a KFF analysis, an inpatient admission for COVID-19 could result in $1,300 in out-of-pocket costs for someone insured under an employer-sponsored plan—costs could be much higher for those seriously ill from COVID-19. Find out more here.
(Source: Kasier Family Foundation, August 20, 2020)